Icp-723
Primary Central Nervous System Tumors Harboring NTRK Fusion
Beijing InnoCare Pharma Tech Co., Ltd.Phase 1/2
—
Rating in progress
Icp-723 in Primary Central Nervous System Tumors Harboring NTRK Fusion is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active